Latest News
Web Date: January 26, 2009

FDA Clears Stem Cell Clinical Trial

Testing in humans is a milestone in a field fraught with controversy
Department: Government & Policy | Collection: Stem Cells

The Food & Drug Administration has given Geron, a small California-based biotech company, the green light to inject living cells manufactured from human embryonic stem cells into a handful of patients with spinal cord injuries.

The trials, set to begin this summer, will be the first in the world to test the safety of a therapy derived from human embryonic stem cells in people.

A lot of . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society